All terms in GO
| Label | Id | Description |
|---|---|---|
| positive regulation of adult salivary gland boundary specification | GO_0045711 |
Any process that activates or increases the frequency, rate or extent of salivary gland determination in an adult organism.
|
| cellular response to haloperidol | GO_1905120 |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a haloperidol stimulus.
|
| regulation of glucosylceramidase activity | GO_1905123 |
Any process that modulates the frequency, rate or extent of glucosylceramidase activity.
|
| negative regulation of glucosylceramidase activity | GO_1905124 |
Any process that stops, prevents or reduces the frequency, rate or extent of glucosylceramidase activity.
|
| GO_1905121 | GO_1905121 | |
| GO_1905122 | GO_1905122 | |
| obsolete purine metabolic process | GO_0006143 |
OBSOLETE. (Was not defined before being made obsolete).
|
| fin regeneration | GO_0031101 |
The regrowth of fin tissue following its loss or destruction.
|
| adenine catabolic process | GO_0006146 |
The chemical reactions and pathways resulting in the breakdown of adenine, 6-aminopurine, one of the 5 main bases found in nucleic acids and a component of numerous important derivatives of its corresponding ribonucleoside, adenosine.
|
| adenine metabolic process | GO_0046083 |
The chemical reactions and pathways involving adenine, 6-aminopurine, one of the five main bases found in nucleic acids and a component of numerous important derivatives of its corresponding ribonucleoside, adenosine.
|
| neuron projection regeneration | GO_0031102 |
The regrowth of neuronal processes such as axons or dendrites in response to their loss or damage.
|
| guanine catabolic process | GO_0006147 |
The chemical reactions and pathways resulting in the breakdown of guanine, 2-amino-6-hydroxypurine, a purine that is one of the five main bases found in nucleic acids and a component of a number of phosphorylated guanosine derivatives whose metabolic or regulatory functions are important.
|
| inosine catabolic process | GO_0006148 |
The chemical reactions and pathways resulting in the breakdown of inosine, hypoxanthine riboside, a nucleoside found free but not in combination in nucleic acids except in the anticodons of some tRNAs.
|
| inosine metabolic process | GO_0046102 |
The chemical reactions and pathways involving inosine, hypoxanthine riboside, a nucleoside found free but not in combination in nucleic acids except in the anticodons of some tRNAs.
|
| oligodendrocyte cell fate specification | GO_0021778 |
The process in which a cell becomes capable of differentiating autonomously into an oligodendrocyte in an environment that is neutral with respect to the developmental pathway. Upon specification, the cell fate can be reversed.
|
| glial cell fate specification | GO_0021780 |
The process in which a cell becomes capable of differentiating autonomously into a glial cell in an environment that is neutral with respect to the developmental pathway. Upon specification, the cell fate can be reversed.
|
| deoxyinosine catabolic process | GO_0006149 |
The chemical reactions and pathways resulting in the breakdown of deoxyinosine, hypoxanthine deoxyriboside.
|
| purine deoxyribonucleoside catabolic process | GO_0046124 |
The chemical reactions and pathways resulting in the breakdown of any one of a family of organic molecules consisting of a purine base covalently bonded to a sugar deoxyribose (a deoxyribonucleoside).
|
| deoxyinosine metabolic process | GO_0046094 |
The chemical reactions and pathways involving deoxyinosine, hypoxanthine deoxyriboside.
|
| oligodendrocyte cell fate commitment | GO_0021779 |
The process in which the developmental fate of a cell becomes restricted such that it will develop into an oligodendrocyte.
|